Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

Science

Volumn 350, Issue 6263, 2015, Pages 972-978

  Vacchelli, Erika ^a,b,c,d,e   Ma, Yuting ^{a,b,c,d,e,f,g}   Baracco, Elisa E ^a,b,c,h   Sistigu, Antonella ⁱ   Enot, David P ^a,b,c   Pietrocola, Federico ^a,b,c,h   Yang, Heng ^{a,b,c,d,e,f,g}   Adjemian, Sandy ^a,b,c   Chaba, Kariman ^a,b,c,d   Semeraro, Michaela ^a,b,j   Signore, Michele ^k   Ninno, Adele De ^l   Lucarini, Valeria ^k   Peschiaroli, Francesca ^k   Businaro, Luca ^l   Gerardino, Annamaria ^l   Manic, Gwenola ⁱ   Ulas, Thomas ^m   Günther, Patrick ^m   Schultze, Joachim L ^m   Kepp, Oliver ^a,b,c,d,e   Stoll, Gautier ^a,b,c,d,e   Lefebvre, Céline ^a,n   Mulot, Claire ^b,o   Castoldi, Francesca ^a,b,c,h,p   Rusakiewicz, Sylvie ^a,b,j   Ladoire, Sylvain ^q,r   Apetoh, Lionel ^q,r   Pedro, José Manuel Bravo San ^a,b,c,d,e   Lucattelli, Monica ^s   Delarasse, Cécile ^t   Boige, Valérie ^a,b   Ducreux, Michel ^a,h   Delaloge, Suzette ^a,n   Borg, Christophe ^u   André, Fabrice ^a,n   Schiavoni, Giovanna ^k   Vitale, Ilio ^i,v   Laurent Puig, Pierre ^b,o,w   Mattei, Fabrizio ^k   Zitvogel, Laurence ^a,b,h,j   Kroemer, Guido ^{a,b,c,d,e,w,x}   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f SUZHOU INSTITUTE OF SYSTEMS MEDICINE   (China)

^g PEKING UNION MEDICAL COLLEGE   (China)

^h CE Saclay   (France)

ⁱ REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^j Center of Clinical Investigations in Biotherapies of Cancer CICBT 507   (France)

^k ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^l CNR   (Italy)

^m UNIVERSITY OF BONN   (Germany)

ⁿ Universite Paris Sud   (France)

^o Therapeutic Implications Laboratoire d'Excellence GR Ex   (France)

^p Sotio   (Czech Republic)

^q CENTRE GEORGES FRANÇOIS LECLERC   (France)

^r UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^s UNIVERSITY OF SIENA   (Italy)

^t PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^u UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^v UNIVERSITY OF ROME TOR VERGATA   (Italy)

^w HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^x KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN 1; ANTHRACYCLINE; CATHEPSIN G; DOXORUBICIN; FORMYL PEPTIDE RECEPTOR 1; FORMYLPEPTIDE RECEPTOR; LIPOCORTIN 1; MITOXANTRONE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; FPR1 PROTEIN, HUMAN; FPR1 PROTEIN, MOUSE;

ALLELE; CANCER; CHEMOTHERAPY; HETEROZYGOSITY; IMMUNE SYSTEM; IMMUNITY; PEPTIDE; PROTEIN; PROTEOMICS; TUMOR;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BONE MARROW; BONE MARROW CELL; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; DENDRITIC CELL; FORMYLATION; GENE FREQUENCY; HETEROZYGOSITY; HOMOZYGOSITY; HOST CELL; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LIVER CELL; METASTASIS FREE SURVIVAL; MITOCHONDRION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR IMMUNITY; ADJUVANT CHEMOTHERAPY; ANIMAL; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LEUKOCYTE; METABOLISM; MOUSE; NEOPLASMS; PHYSIOLOGY; T LYMPHOCYTE; TUMOR CELL LINE;

MURINAE; MUS;

ALLELES; ANIMALS; ANNEXIN A1; ANTHRACYCLINES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, INNATE; LEUKOCYTES; MICE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FORMYL PEPTIDE; T-LYMPHOCYTES;

EID: 84947763610     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aad0779     Document Type: Article

References (29)

1. L. Zitvogel, L. Galluzzi, M. J. Smyth, G. Kroemer, Immunity 39, 74-88 (2013).
2. A. Sklan, Lancet Oncol. 15, e422 (2014).
3. C. Denkert et al., J. Clin. Oncol. 28, 105-113 (2010).
4. M. L. Broz et al., Cancer Cell 26, 638-652 (2014).
5. L. Senovilla et al., OncoImmunology 1, 1323-1343 (2012).
6. L. Senovilla et al., Science 337, 1678-1684 (2012).
7. L. Apetoh et al., Nat. Med. 13, 1050-1059 (2007).
8. G. Kroemer, L. Senovilla, L. Galluzzi, F. André, L. Zitvogel, Nat. Med. 21, 1128-1138 (2015).
9. A. Sistigu et al., Nat. Med. 20, 1301-1309 (2014).
10. G. Kroemer, L. Galluzzi, O. Kepp, L. Zitvogel, Annu. Rev. Immunol. 31, 51-72 (2013).
11. L. Zitvogel, O. Kepp, G. Kroemer, Cell 140, 798-804 (2010).
12. P. E. Marques et al., Hepatology 56, 1971-1982 (2012).
13. B. McDonald et al., Science 330, 362-366 (2010).
14. R. Seifert, K. Wenzel-Seifert, Life Sci. 73, 2263-2280 (2003).
15. K. Wenzel-Seifert, R. Seifert, Naunyn-Schmiedebergs Arch. Pharmacol. 367, 509-515 (2003).
16. H. M. Miettinen, PLOS ONE 6, e28712 (2011).
17. A. Sahagun-Ruiz et al., Genes Immun. 2, 335-342 (2001).
18. F. Ghiringhelli et al., Nat. Med. 15, 1170-1178 (2009).
19. N. Prevete et al., Oncogene 34, 3826-3838 (2015).
20. R. Sun et al., J. Immunol. 173, 428-436 (2004).
21. W. Wang et al., Cell. Mol. Immunol. 12, 615-624 (2015).
22. E. J. Tucker et al., Cell Metab. 14, 428-434 (2011).
23. Y. Li, D. Ye, J. Mol. Med. 91, 781-789 (2013).
24. J. Huang et al., Br. J. Cancer 102, 1052-1060 (2010).
25. A. L. Stenfeldt et al., Inflammation 30, 224-229 (2007).
26. Y. Ma et al., Immunity 38, 729-741 (2013).
27. A. Boissonnas, L. Fetler, I. S. Zeelenberg, S. Hugues, S. Amigorena, J. Exp. Med. 204, 345-356 (2007).
28. Y. Ma et al., Cancer Res. 74, 436-445 (2014).
29. L. Businaro et al., Lab Chip 13, 229-239 (2013).